While this is all great news for Verzenio, Lilly isn't stopping its ambitions in oncology care with just one treatment. Right now, the company has seven clinical trials underway exploring new ...

I’ve received texts from family members thanking me for what I’ve done,” volunteer Tom Kallas said. “It’s heartwarming to ...

Bloomfield Hills internal medicine physician Amjad Rass was excited to reunite with family in Syria last month for the first ...

Pete Yonkman, president of Cook Group and Cook Medical, was among the speakers Monday at the official launch of the new ...

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...

Health-care companies rose as traders rotated back into the sector amid optimism about blockbuster drugs. Novo Nordisk shares rose by more than 8% for one of their biggest gains in recent years after ...

The S&P 500 advanced 0.92% to 6,067.70, with technology shares seeing the biggest gains among sectors. The Technology Select ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

When Emily Munson started working for Indiana Disability Rights in 2015, 40 employers in the state were permitted to pay ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...